C07K 16/1232
Escherichia
Official title: Escherichia (G)
C07K16/1232 (Escherichia) appears on 216 US grants and 277 published applications in this corpus.
Search patents in C07K- Granted patents
- 216
- Published applications
- 277
- Assignees
- 176
- Inventors
- 527
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 3 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 4 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 0 | 0 |
| 1994 | 2 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 2 | 0 |
| 1998 | 3 | 0 |
| 1999 | 3 | 0 |
| 2000 | 3 | 0 |
| 2001 | 3 | 2 |
| 2002 | 2 | 7 |
| 2003 | 6 | 10 |
| 2004 | 1 | 10 |
| 2005 | 3 | 4 |
| 2006 | 2 | 6 |
| 2007 | 5 | 13 |
| 2008 | 8 | 3 |
| 2009 | 3 | 10 |
| 2010 | 5 | 10 |
| 2011 | 5 | 13 |
| 2012 | 4 | 9 |
| 2013 | 5 | 8 |
| 2014 | 10 | 15 |
| 2015 | 12 | 11 |
| 2016 | 13 | 19 |
| 2017 | 9 | 14 |
| 2018 | 12 | 15 |
| 2019 | 8 | 10 |
| 2020 | 12 | 11 |
| 2021 | 15 | 17 |
| 2022 | 7 | 12 |
| 2023 | 7 | 11 |
| 2024 | 8 | 15 |
| 2025 | 14 | 14 |
| 2026 | 1 | 8 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Engineered binding proteins for recognition of bacteria11 Aug 2026US 12,704,514 B2Massachusetts Institute of Technology
- Compositions and methods for the treatment of immunodeficiency18 Nov 2025US 12,473,351 B2Adma Biomanufacturing, LLC
- Pathogen binding proteins14 Oct 2025US 12,441,783 B2Bactolife APS
- FimH mutant, compositions therewith and use thereof30 Sep 2025US 12,428,449 B2Janssen Pharmaceuticals, Inc.
- Bacteria-derived vesicles and uses thereof26 Aug 2025US 12,397,047 B2Exocure Sweden AB
- Compositions and methods for the treatment of immunodeficiency24 Sep 2026US 2026/0285950 A1Adma Biomanufacturing, LLC
- Anti-etec adhesin protein antibodies and methods of use17 Sep 2026US 2026/0274929 A1University of Massachusetts
- E. coli fimh mutants and uses thereof7 May 2026US 2026/0124286 A1Pfizer Inc.
- Method and reagents for ultrasensitive immunoassay19 Mar 2026US 2026/0079158 A1Agri-Analysis, LLC
- Polynucleotide compositions and uses thereof5 Mar 2026US 2026/0061042 A1Pfizer Inc.
Most cited
By later US patents
- High affinity human antibodies and human antibodies against digoxin211US 6,255,458 B1GenPharm International, Inc. · 2001
- Proteins and nucleic acids from meningitis/sepsis-associated Escherichia coli104US 8,758,764 B2J. Craig Venter Institute, Inc. · 2014
- Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens96US 6,033,864 AThe Regents of the University of California · 2000
- Method of producing antibody-fortified dry whey72US 5,017,372 AMedicis Corporation · 1991
- Production of monoclonal antibodies against bacterial adhesins67US 4,443,549 AMolecular Genetics, Inc. · 1984